BMD Health is independent reference lab that is certified for high-complexity diagnostic testing by CLIA and COLA. We strive to create a better relationship with provider and patient by providing an array of comprehensive molecular diagnostic panels with fast reliable turnaround times.
Specializing in molecular diagnostics (PCR Testing), with a focus on antibiotic stewardship, we provide clinicians with the most advanced methodology for pathogen detection, quantification, and resistance gene identification. These results are delivered through a streamlined platform incorporating regional sensitivity, medication costs, antibiotic spectrum of activity, and FDA guidance.
We understand that undiagnosed and untreated infections can have dire consequences to not only the health of your residents and staff, but to your business reputation. That is why we offer the most comprehensive, cost-effective, convenient, rapid and accurate UTI, COVID-19 and Flu A and B testing available.
Our goal is to provide the most comprehensive, convenient, rapid and accurate lab testing available, helping long-term care residences, in-home care practices, clinics, hospitals, and other facilities prevent dangerous outbreaks, reduce readmittance rates and encourage antibiotic stewardship.
Long term care residences are susceptible to pathogen outbreaks, such as C difficile, Norovirus, flu, etc. Traditional testing uses the Culture and Sensitivity method, which takes time to grow and test. This outdated model is at best 60% accurate.
Why Choose Our Services
There are plenty of reasons why facilities have turned to BMD. Here are just a few.
We believe in treating patients with antibiotics only when absolutely necessary, and we do all we can to guide clinicians towards the most effective and suitable treatment regimen.
Fast and Convenient
Get fast, accurate, and convenient UTI, COVID-10, and Flu A & B Testing and Results.
We utilize the “gold standard” when testing for COVID-19 to ensure accuracy.
Many times the long term care facility is dependent on a hospital lab to properly identify infection and prescribe antibiotics.
Cost Containment Recommendations
Lab results include cost containment. Recommended treatments (pill, injection, IV) are listed long with the cost per dosage.
Sanford Guide Partnership
Great partnerships have been vital in helping us lower readmittance rates from 30% to 6%.
Along with our strong network of lab partners, we test for over 125 pathogens, and identify over 30 antibiotic resistant gene markers.
Plus, our well-staffed labs allow us to offer next day turnaround, increasing test accuracy. In collaboration with the world’s foremost authority on infectious disease consulting, The Sanford Guide, BMD is able to provide recommended treatment protocols that help us reduce readmittance.
Our patient-centered, value-based care solutions enable providers to make informed treatment decisions that could avoid inappropriate therapy, excess costs, adverse drug events, and the progression of disease. One key difference between BMD and our competitors is that we focus on client service rather than profits. For example, we go out to our clients to pick up and even take samples. This increases our costs, but eliminates your costs and risks associated with transporting patients.
Finally, our reports provide not only more reliable test results, but also include recommendations for overall patient care, potentially reducing the spread of infectious trending pathogens. In short, better client AND patient outcomes.
Get Started Today!
Our patient-centered, value-based care solutions enable providers to make informed treatment decisions that could avoid inappropriate therapy, excess costs, adverse drug events, and the progression of disease. Let's get started.